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necrosis of all regional lymph node metastases:
morphologic description of a presumed
immune-mediated event
Andrew Mitchell1* and Yves Bendavid2Abstract
Medullary carcinoma is a rare type of colon cancer with characteristic clinical and molecular features. Notably,
despite its high-grade histology, the prognosis is generally better than for colonic adenocarcinoma of the usual
type. We present herein a singular case of medullary colon cancer in which all of numerous lymph node metastases
in the surgical resection specimen were completely necrotic in the face of a wholly viable primary tumor. Possible
mechanisms are discussed with emphasis on immune-mediated factors.
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Medullary cancer is a rare but well-characterized type of
colon carcinoma [1,2]. Although displaying high-grade
histologic features, in general there are fewer lymph node
metastases and better overall survival compared to typical
adenocarcinomas of the colon. We describe a singular
case of previously untreated medullary colon cancer in
which all lymph node metastases were entirely necrotic
whereas the primary tumor was, in stark contrast, com-
pletely histologically viable. Although we cannot provide a
definitive explanation for this phenomenon, an immune-
mediated mechanism seems most likely.Case presentation
A 75 year old woman presented with diffuse pain in her
arms and legs of recent onset. Neurologic consultation
led to a diagnosis of polyneuropathy of uncertain eti-
ology, likely paraneoplastic in origin. Her past medical
history included hypothyroidism and idiopathic sensory* Correspondence: plaines@me.com
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article, unless otherwise stated.neuronopathy (both of at least fifteen years duration),
pernicious anemia, oculopharyngeal dystrophy, arterial
hypertension, atherosclerotic heart disease, chronic ob-
structive pulmonary disease, and appendectomy. She
had stopped smoking forty years previously.
As part of a subsequent “neoplastic workup” a PET-
scan revealed a highly metabolically active mass in the
cecum, with no other sites suspicious for neoplasia identi-
fied. A CT-scan of the thorax was negative. She was not
anemic, and stated she was completely asymptomatic re-
garding the cecal lesion. An attempt at colonoscopic bi-
opsy was unsuccessful, as, due to pain and significant
diverticulosis, the colonoscope could not be passed be-
yond the sigmoid. Shortly thereafter, a laparoscopic right
hemicolectomy was performed.
Postoperatively, the patient received standard chemo-
therapy for colorectal carcinoma. Nearly one year fol-
lowing surgery, there is no evidence of recurrent disease.
Her polyneuropathy has resolved.
Materials and methods
All formalin-fixed, paraffin-embedded tissue blocks from
the surgical resection specimen were cut at 4 microns
and routinely stained with hematoxylin-phloxin-saffranind Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Mitchell and Bendavid Diagnostic Pathology 2014, 9:204 Page 2 of 5
http://www.diagnosticpathology.org/content/9/1/204(HPS). Selected tissue blocks were stained with the histo-
chemical stain PAS with diastase for the detection of epi-
thelial mucin and the following immunohistochemical
markers: pancytokeratin (AE1/AE3, Millipore, 1:1000),
cytokeratin Cam 5.2 (5D3, Becton Dickinson, 1:2), calreti-
nin (SP65, Roche, prediluted), CEA (II-7, Dako, 1:1000),
CDX-2 (EPR2764Y, Roche, prediluted), EBV (C1, Dako,
1:1000), MLH1 (M1, Ventana, prediluted), PMS2 (EPR
3949, Ventana, prediluted), MSH2 (G219-1129, Ventana,
prediluted), and MSH6 (44, Ventana, prediluted). Mutation
of the BRAF V600E gene was evaluated by polymerase
chain reaction according to a standard protocol.
Pathologic findings
Macroscopic examination of the right hemicolectomy
specimen revealed a discoid cecal mass 4 cm in the largest
dimension with invasion of the muscle wall. There was no
infiltration of surrounding soft tissues or of the visceral
peritoneum (serosa). Multiple firm, whitish, lymph nodes
suggestive of metastatic tumor were readily found in the
mesentery. The rest of the specimen was normal.
Microscopic examination demonstrated features typical
of medullary cancer (MC) (Figure 1a, b, c). Tumor necro-
sis was absent. The tumor cells were positive with the epi-
thelial markers pancytokeratine (Figure 1d) and Cam 5.2,
calretinin, and CDX-2 (weak) in accordance with the diag-
nosis. CEA and EBV immunostaining were negative. PAS
with diastase staining confirmed the absence of intra- or
extracellular mucin. Microsatellite instability – high
(MSI-high) was demonstrated by immunohistochemicalFigure 1 Histology of the primary tumor. a) The well-circumscribed prim
wall (right) shows a marked Crohn’s-like inflammatory infiltrate. b and c) Tu
lymphocytes. Gland formation is absent. There are high-grade cytologic fea
positivity of the tumor cells. Normal colonic epithelium at bottom right prostaining: MLH1/PMS2 negative, MSH2/MSH6 positive.
The BRAF V600E gene was mutated.
Although no peritumoral lymphovascular invasion was
seen, 11 of 32 resected peri-colic lymph nodes were
positive. Staging of the tumor was therefore T2 N2b M0
[3]. However, all metastatic foci showed complete tumor
necrosis surrounded by a brisk granulomatous inflam-
matory reaction. In none of the involved lymph nodes
were any viable tumor cells found (Figure 2a, b, c, e, f, g).
Staining with pancytokratine and Cam 5.2 showed strong
positivity in multiple lymph nodes, confirming the epithe-
lial nature of the necrotic foci (Figure 2d).
Discussion
Medullary carcinoma (MC) of the colon is a rare tumor
with characteristic histologic features representing 5-8/
10,000 colon cancer cases. An analysis of all 50 cases of
MC in the Surveillance, Epidemiology and End Results
(SEER) database from 1973 to 2006 concluded that it oc-
curs most commonly in the proximal colon (74%), favors
older women, is less likely to feature lymph node metas-
tases, and has a good prognosis with one and two year
relative survival rates of 92.7% and 73.8% [1].
Macroscopically and microscopically, MC is well circum-
scribed with a “pushing” or “expanding” growth pattern. It
often grows to a large size (the majority at diagnosis are
greater than 7 cm) with infiltration of adjacent structures.
The tumor cells have “high grade” cytologic features: high
nuclear/cytoplasmic ratios, round to oval nuclei, large
amphophilic nucleoli, and vesicular chromatin. Mitoses areary medullary carcinoma is on the left (arrows). The caecal muscular
mor cells are arranged in cords with associated intra-tumoral
tures and several mitoses. Necrosis is absent. d) Pancytokeratin
vides a positive internal control.
Figure 2 Histology of the lymph node metastases. a, b and c) Several lymph nodes showing necrotic metastases surrounded by
granulomatous inflammation. Viable tumor cells are completely absent. d) Pancytokeratin positivity of the necrotic tumor cells within one of the
lymph nodes. e and f) High power views of lymph nodes with necrotic tumor and associated granulomatous inflammation. Viable tumor cells
are completely absent. g) High power view of necrotic tumor within lymph node. Viable tumor cells are completely absent.
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are arranged in nests, cords, and sheets and may widely
infiltrate the intestinal wall; geographic necrosis and peri-
neural and angiolymphatic invasion are common [2]. In-
tense intratumoral or peritumoral lymphocytic infiltrates,
lymphocytic infiltrates at the advancing tumor margin and
conspicuous “Crohn’s-like” lymphoid reactions are com-
mon [4]. Positivity with neuroendocrine immunohisto-
chemical markers is found in approximately one third of
cases [2].
Microsatellite instability – high (MSI-high): MLH1/
PMS2 negative, MSH2/MSH6 positive is typical [5].BRAF V600E mutation, as seen here, indicates a spor-
adic tumor [6].
The differential diagnosis of MC includes poorly dif-
ferentiated colorectal adenocarcinoma, neuroendocrine
carcinoma and “lymphoepithelioma-like carcinoma”, for
which the differential diagnostic features are discussed
elsewhere [2,7].
To the best of our knowledge the present case is unique,
as concomitant with a wholly viable primary MC tumor,
all numerous (11) lymph node metastases were completely
necrotic at the time of surgery. In contrast, of the 68 MCs
in the series of Wick et al [2] the authors stated “there
Mitchell and Bendavid Diagnostic Pathology 2014, 9:204 Page 4 of 5
http://www.diagnosticpathology.org/content/9/1/204was no difference in the microscopic appearance of lymph
nodal tumor deposits vis-à-vis that of the primary neo-
plasms”. Also of interest, in another large study of MC
only one of 50 cases (2%) had greater than 7 lymph node
metastases [1].
Do these findings represent an example of “spontan-
eous tumor regression”? Criteria for the diagnosis of
spontaneous regression were put forward nearly fifty
years ago: 1) histologic regression of biopsy proven me-
tastases, 2) radiologic regression of presumed neoplastic
disease, and 3) regression of metastatic tumor after ther-
apy considered ineffective [8]. The first criterion would
most closely correspond to the histologic findings we
describe. Given its incidence and prevalence, spontan-
eous regression of colorectal cancer is an extremely rare
event, with only 21 cases reported between 1900 and
2005 according to a major review [8]. All examples were
moderately to poorly differentiated adenocarcinomas of
the usual type. Regression almost invariably involved the
primary tumor or metastases following removal of the
primary tumor. It should be noted, however, that in sev-
eral cases where regression of metastatic disease was re-
ported, regression, or not, of the primary tumor was not
clearly specified.
Numerous hypotheses concerning the mechanism(s) of
tumor regression have been proposed, none conclusive (8).
Similarly, we cannot provide a precise explanation for this
phenomenon, but the interplay of patient-specific factors
and immune-mediated events is likely. Regarding patient
factors, there had been no neoadjuvant therapy. Causes of
local ischemic events such as bowel torsion (volvulus) or
tissue entrapment in an internal hernia or by adhesions
were not observed at surgery. However, the patient had
several auto immune-mediated diseases (hypothyroidism,
idiopathic sensory neuronopathy, and pernicious anemia),
suggesting heightened activity of her immune system and,
perhaps, increased immunosurveillance.
As the primary tumor was entirely viable, the potential
role of the lymph node microenvironment in inducing
tumor necrosis is worthy of consideration. One can specu-
late that tumor antigen processing by lymph node antigen
presenting cells (APCs) may have instigated a localized
immunologic response leading to widespread cell necrosis.
This would imply, conversely, that the APCs infiltrating
and surrounding the primary tumor itself were incapable
of instigating such a response: the tumor cells metastatic
to the lymph nodes were therefore likely viable.
Tumor cell necrosis, formally regarded as a passive
phenomenon, is now considered a form of programmed
cell death (type III PCD) [9]. Whereas apoptosis (type II
PCD) involves the death of individual cells, necrosis in-
volves large cell numbers. It is mediated by complex sig-
naling pathways that are activated when, for example,
inadequate vascularization leads to ischemia and hypoxiawith resulting cell energy deprivation; a variety of anti-
cancer drugs also induce necrosis. Tumor cell necrosis
in turn further stimulates the immune system: the re-
lease of a variety of cytoplasmic molecules to the extra-
cellular space upon loss of cell membrane integrity leads
to activation of APCs and macrophages. Dendritic cell
maturation and T-cell proliferation subsequently occur
with optimization of tumor antigen presentation and
phagocytosis of dead cells. [9]. As such, although the pri-
mary initiating event in our case is unknown, we propose
that this “lymph node-limited tumor necrosis” may be due
to the ability of lymph node specific immune cells to
mount a tumor directed immune response.
Finally, regarding the patient’s polyneuropathy, the devel-
opment of symptoms before tumor detection and the reso-
lution of symptoms following tumor removal clinically
support a paraneoplastic etiology [10]. However, no testing
for neuro-oncologic antibodies was performed. Paraneo-
plastic neurological syndromes due to colon cancer are ex-
tremely rare, with sensory neuropathy and vasculitis having
been described [11]. Of note, it has been observed that tu-
mors causing paraneoplastic neurologic disorders are often
“heavily infiltrated with inflammatory cells” and have a bet-
ter prognosis than histologically identical tumors with no
paraneoplastic neurologic manifestations [10].
Conclusion
In summary, we present a unique case of medullary colon
cancer. The simultaneous occurrence of necrotic lymph
node metastases and a viable primary tumor is possibly
explained by an immunologic response in the lymph node
microenvironment. The patient’s history of multiple auto-
immune diseases raises questions as to the role of her “ac-
tivated” immune system in responding to the metastases.
This case, albeit of morphologic interest, and perhaps
representing a form of spontaneous regression, raises im-
portant questions relating to the immunologic response to
tumor cells instigated within lymph nodes.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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